Putnam Investments’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,101,444
| Closed | -$4.08M | – | 1463 |
|
|
2016
Q1 | $4.08M | Sell |
1,101,444
-323,856
| -23% | -$1.2M | 0.01% | 718 |
|
|
2015
Q4 | $14.4M | Sell |
1,425,300
-488,300
| -26% | -$4.93M | 0.03% | 371 |
|
|
2015
Q3 | $26M | Sell |
1,913,600
-91,174
| -5% | -$1.24M | 0.06% | 266 |
|
|
2015
Q2 | $38M | Sell |
2,004,774
-325,200
| -14% | -$6.17M | 0.08% | 236 |
|
|
2015
Q1 | $61M | Sell |
2,329,974
-598,200
| -20% | -$15.7M | 0.12% | 182 |
|
|
2014
Q4 | $61.3M | Sell |
2,928,174
-645,572
| -18% | -$13.5M | 0.13% | 172 |
|
|
2014
Q3 | $119M | Buy |
3,573,746
+121,650
| +4% | +$4.06M | 0.25% | 94 |
|
|
2014
Q2 | $111M | Buy |
3,452,096
+1,546,484
| +81% | +$49.6M | 0.24% | 100 |
|
|
2014
Q1 | $87.9M | Buy |
1,905,612
+1,893,486
| +15,615% | +$87.3M | 0.2% | 119 |
|
|
2013
Q4 | $860K | Sell |
12,126
-192
| -2% | -$13.6K | ﹤0.01% | 1239 |
|
|
2013
Q3 | $1.06M | Sell |
12,318
-1,101
| -8% | -$94.4K | ﹤0.01% | 1204 |
|
|
2013
Q2 | $850K | Buy |
+13,419
| New | +$850K | ﹤0.01% | 1229 |
|